The ApoB/ApoA1 ratio is considered a more accurate indicator for assessing the balance between atherogenic and antiatherogenic lipoproteins and is an ideal marker for lipid alterations associated with IR and MetS. The gene discussed is APOA1; the disease is metabolic syndrome.